In:
Thrombosis and Haemostasis, Georg Thieme Verlag KG, Vol. 79, No. 02 ( 1998), p. 378-382
Kurzfassung:
The effects of the selective alpha-1-adrenoceptor antagonist doxazosin on metabolic and fibrinolytic parameters were studied in hypertensive patients with various degrees of fasting plasma insulin levels (Group A: 22.5 ± 3 μU/ml, Group B: 8.1 ± 1.5 μU/ml; p 〈 0.01) to disclose a potential link between a doxazosin-induced alteration of insulin and/or lipid metabolism and possible changes of these parameters on the fibrinolytic system. Doxazosin treatment resulted in a dose-dependent reduction of basal insulin levels in group A to 16 ± 3 μU/ml; p 〈 0.05. This finding was paralleled by a dose-dependent increase in t-PAmass concentration in the same patient group (basal t-PAmass from 9.7 ± 1 to 15.5 ± 2 ng/ml; p 〈 0.05). As PAI-1 “active” as well as total antigen levels were not altered in parallel, the net effect on the endogenous fibrinolytic system is an increase of the fibrinolytic potential.
Materialart:
Online-Ressource
ISSN:
0340-6245
,
2567-689X
DOI:
10.1055/s-0037-1614995
Sprache:
Englisch
Verlag:
Georg Thieme Verlag KG
Publikationsdatum:
1998
Permalink